Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Pittsburgh
Coherus Oncology, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Syndax Pharmaceuticals